NO955325L - Propansyrederivater, deres fremstilling og terapeutiske anvendelse - Google Patents

Propansyrederivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO955325L
NO955325L NO955325A NO955325A NO955325L NO 955325 L NO955325 L NO 955325L NO 955325 A NO955325 A NO 955325A NO 955325 A NO955325 A NO 955325A NO 955325 L NO955325 L NO 955325L
Authority
NO
Norway
Prior art keywords
preparation
acid derivatives
propanoic acid
therapeutic use
therapeutic
Prior art date
Application number
NO955325A
Other languages
English (en)
Other versions
NO305084B1 (no
NO955325D0 (no
Inventor
Benoit Marabout
Mireille Sevrin
Jacques Froissant
Emmanuelle Dachary
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO955325D0 publication Critical patent/NO955325D0/no
Publication of NO955325L publication Critical patent/NO955325L/no
Publication of NO305084B1 publication Critical patent/NO305084B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO955325A 1994-12-29 1995-12-28 Propansyrederivater, medikament og farmas°ytisk preparat inneholdende et slikt derivat NO305084B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415836A FR2728902B1 (fr) 1994-12-29 1994-12-29 Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO955325D0 NO955325D0 (no) 1995-12-28
NO955325L true NO955325L (no) 1996-07-01
NO305084B1 NO305084B1 (no) 1999-03-29

Family

ID=9470389

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955325A NO305084B1 (no) 1994-12-29 1995-12-28 Propansyrederivater, medikament og farmas°ytisk preparat inneholdende et slikt derivat

Country Status (26)

Country Link
US (1) US5614517A (no)
EP (1) EP0719776B1 (no)
JP (1) JPH08239383A (no)
KR (1) KR960022518A (no)
CN (1) CN1058009C (no)
AR (1) AR002015A1 (no)
AT (1) ATE172973T1 (no)
AU (1) AU697988B2 (no)
BR (1) BR9506105A (no)
CA (1) CA2166233A1 (no)
CO (1) CO4700297A1 (no)
CZ (1) CZ348895A3 (no)
DE (1) DE69505781T2 (no)
DK (1) DK0719776T3 (no)
ES (1) ES2126232T3 (no)
FI (1) FI956299A (no)
FR (1) FR2728902B1 (no)
HU (1) HU215393B (no)
IL (1) IL116596A (no)
NO (1) NO305084B1 (no)
NZ (1) NZ280766A (no)
PL (1) PL181811B1 (no)
RU (1) RU2155764C2 (no)
SK (1) SK280546B6 (no)
TW (1) TW385311B (no)
ZA (1) ZA9511035B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806723B1 (fr) * 2000-03-23 2002-05-10 Sanofi Synthelabo DERIVES D'ACIDE 8-OXO-5,8-DIHYDRO-6H-DIBENZO [a,g] QUINOLIZINE-13-PROPANOIQUE , LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
CN104127414B (zh) * 2013-05-03 2018-04-13 中国科学院上海药物研究所 一种六氢二苯并[a,g]喹嗪类化合物的药物用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013616A (en) * 1971-11-22 1977-03-22 Wallace Richard A Mixed polymeric structural material and method

Also Published As

Publication number Publication date
PL312080A1 (en) 1996-07-08
HU9503846D0 (en) 1996-02-28
TW385311B (en) 2000-03-21
CA2166233A1 (en) 1996-06-30
HUT74186A (en) 1996-11-28
AR002015A1 (es) 1998-01-07
FR2728902B1 (fr) 1997-01-31
ZA9511035B (en) 1996-07-01
DE69505781T2 (de) 1999-06-17
NO305084B1 (no) 1999-03-29
HU215393B (hu) 1998-12-28
SK280546B6 (sk) 2000-03-13
CN1131154A (zh) 1996-09-18
DE69505781D1 (de) 1998-12-10
ATE172973T1 (de) 1998-11-15
EP0719776B1 (fr) 1998-11-04
AU4070895A (en) 1996-07-04
NO955325D0 (no) 1995-12-28
EP0719776A1 (fr) 1996-07-03
CN1058009C (zh) 2000-11-01
ES2126232T3 (es) 1999-03-16
CZ348895A3 (en) 1996-07-17
SK165895A3 (en) 1996-07-03
RU2155764C2 (ru) 2000-09-10
KR960022518A (ko) 1996-07-18
IL116596A0 (en) 1996-03-31
IL116596A (en) 1998-10-30
JPH08239383A (ja) 1996-09-17
DK0719776T3 (da) 1999-07-19
FI956299A (fi) 1996-06-30
US5614517A (en) 1997-03-25
AU697988B2 (en) 1998-10-22
FR2728902A1 (fr) 1996-07-05
CO4700297A1 (es) 1998-12-29
PL181811B1 (pl) 2001-09-28
NZ280766A (en) 1996-09-25
BR9506105A (pt) 1997-12-23
FI956299A0 (fi) 1995-12-28

Similar Documents

Publication Publication Date Title
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO963499D0 (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
DK1538160T3 (da) Substituerede isochinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel
NO941679D0 (no) Gallesyrederivater, fremgangsmåte for fremstilling og deres anvendelse
NO985977D0 (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
DK374289D0 (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK605489A (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO984714L (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO984713D0 (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO326826B1 (no) Alfa-aminosyreamider, fremstilling og terapeutisk anvendelse derav
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO951811D0 (no) Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO981002D0 (no) Karboksylsyrederivater, deres fremstilling og anvendelse
NO955325L (no) Propansyrederivater, deres fremstilling og terapeutiske anvendelse
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO950560L (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
NO951812D0 (no) Pyrrolderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2002